Data compiled by Redley Lamar · ChainSifter Intelligence
4Suppliers
1Customers
2Debt Items
20Related Chains
Source-Backed Evidence Depth
Silexion Therapeutics Corp (SLXN) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
7Total relationships
3Distinct source URLs
5High confidence
0.827Average confidence
2026-10-29Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
Silexion Therapeutics Corp Suppliers
Ticker
Name
Confidence
Evidence
LEADING-GLOBAL-CDMO
LEADING-GLOBAL-CDMO
90%
Silexion Therapeutics Announces Initiation of GMP Clinical Supply Manufacturing of SIL204 with Leading Global CDMO
WHITE-LION-CAPITAL-LLC
WHITE-LION-CAPITAL-LLC
90%
In connection with the Closing, we also entered into an ordinary share purchase agreement, dated August 13, 2024 and effective as of August 15, 2024 (the “ ELOC Agreement ”) with White Lion Capital, …
GREENSTAR-LP
GREENSTAR-LP
85%
ringa sold to Greenstar, LP, an affiliate of the Moringa sponsor, 1,482 newly issued Moringa ordinary shares at a price of $1,350.00 per share.
BMY
Bristol-Myers Squibb Company
72%
Reciprocal relationship from BMY graph: Reciprocal relationship from SLXN graph: Reciprocal relationship from BMY graph: Reciprocal relationship from SLXN graph: Reciprocal relationship from BMY grap…
Silexion Therapeutics Corp Customers
Ticker
Name
Confidence
Evidence
EMERGING-GROWTH-COMPANY
EMERGING-GROWTH-COMPANY
62%
er the ELOC, which we did not utilize in 2025, after having raised $3.1 million under it in 2024, and (iii) a decrease of $2.3 million in cash received from financing transactions that we entered int…
Silexion Therapeutics Corp Debt Obligations
Instrument
Description
Confidence
Evidence
SLXN-DEBT-12601
Warrants outstanding: 3098636000
90%
xbrl warrant detail from xbrl 2025-12-31.
SLXN-DEBT
Debt stack $2.0M
90%
Market cache reports total debt of $2.0M.
Silexion Therapeutics Corp Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Silexion Therapeutics Corp.
Silexion Therapeutics Corp Ownership
No ownership data on recordNo major institutional ownership relationships found in our database for Silexion Therapeutics Corp.
